ASHTON PAULUS: Open Payments
NPI 1972244333 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 22 payments from 11 companies in 2025. Trend: 2023 $521 · 2024 $748 · 2025 $398
Food & beverage: $398
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 4 | $84 |
| Ardelyx, Inc. | 3 | $60 |
| Travere Therapeutics, Inc. | 3 | $48 |
| OPKO Pharmaceuticals, LLC | 3 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| ANI Pharmaceuticals, Inc. | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| AKEBIA THERAPEUTICS INC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $15 |
Products named: TARPEYO, IBSRELA, RAYALDEE, PURIFIED CORTROPHIN GEL, Kerendia, Auryxia, JYNARQUE, KRYSTEXXA.
Industry payments across NJ — which companies pay providers there.
